Skip to content

Use of Harmonic in Breast Surgery

Harmonic Scalpel vs. Electrocautery Dissection in Modified Radical Mastectomy: A Randomized Controlled Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01587248
Acronym
HMRM
Enrollment
152
Registered
2012-04-30
Start date
2010-03-31
Completion date
2011-08-31
Last updated
2012-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Modified Radical Mastectomy

Keywords

Breast cancer,, Harmonic scalpel,, Electrocautery,, Modified Radical Mastectomy,, Randomized Controlled Trial

Brief summary

To compare harmonic scalpel with electrocautery for outcomes i.e. estimated blood loss (EBL), operating time, drain Volume and drain Days, seroma formation, surgical site infection and postoperative pain in adult females undergoing MRM at a tertiary care hospital. We hypothesized that harmonic yields better outcome than electrocautery dissection.

Detailed description

In this randomized controlled trial, adult females who underwent MRM between April 2010 and July 2011 were randomized to receive either intervention A (harmonic scalpel) or B (electrocautery). The procedure was standardized except elevation of flaps and axillary dissection, that was performed as per randomization. Patients were followed up in clinic for four weeks. The outcomes were estimated blood loss (EBL), operating time, drain Volume and drain Days, complications (seroma, surgical site infection, hematoma and flap necrosis) and postoperative pain.

Interventions

DEVICEHarmonic

Dissection with harmonic scalpel

Dissection in modified radical mastectomy

Sponsors

Aga Khan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Adult females with biopsy proven breast cancer underwent MRM

Exclusion criteria

* Simultaneous procedure (Reconstruction, Sentinel lymph node biopsy)

Design outcomes

Primary

MeasureTime frameDescription
Duration of drains (days)30 daysDurations of drains in place after MRM: Patients were followed in clinic every 3rd day and drains were removed once the volume was \<30ml a day.

Secondary

MeasureTime frameDescription
Operative time3-4 hoursTime taken in minutes from incision to skin closure
Drain Volume30 daysDaily charting of drain volume at a specified time with regular recording in routine clinic follow ups till the drains were is place.
Overall complications30 daysPatients were followed up till 3o days. If any of the following were found, the patient was labelled to have complication: Seroma- fluctuant swelling under the flaps; SSI- as per CDC criteria; Hematoma- swelling under flaps with characteristic bruising; Flap necrosis- partial or complete necrosis of flaps.
Pain24 hoursPain was measured by Visual Analogue score (1-10) by a registered nurse at 24 hours

Countries

Pakistan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026